CClinicalTrials.gg
Status unknownNCT04300439IMEDUUUpdated Mar 9, 2020

Medico-economic Interest of Single-use Ancillary Efficiency® in Fitting a GMK® Total Knee Arthroplasty (TKA)

An interventional study of knee total arthroplasty with two types of ancillaries in Knee Arthropathy, sponsored by Nantes University Hospital. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-09.

Sponsored by Nantes University Hospital · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Clinical studies on single-use ancillaries are still few; medico-economic benefits have to be assessed regarding their design and use.

A foreseeable increase in the number of surgeries in the future, tends to change the techniques and consequently to question the medico-economic context. Single-use ancillaries attempt to provide solutions to today's imperatives and could be relevant from a global medico-economic point of view.

For the moment, the conventional ancillaries for TKA are reused after sterilization.

The objective of the study is to improve the fluidity of the intervention process with cost control.

Read the detailed description

After validation of the inclusion criteria, the surgeon will perform the randomization (1:1): single-use ancillary group or conventional ancillary group. Only the medical team and the block staff will be informed about the ancillary group, not the patient.

The use of the single-use ancillary does not induce any modification of the surgical technique for fitting a TKA. The surgical approach is unchanged and is specific to the surgeon. The appearance and use of the single-use ancillary are similar to the conventional ancillary except for the materials used for their design. Please note that a preliminary training at the beginning of the study will be carried out with the different investigators so that they can handle the different medical devices.

In total, 48 participants will be randomized. The medico-economics assessments will be performed for 20 patients (10 per group) by micro-costing to evaluate the preoperative, intraoperative and post-operative costs : reconditioning time, sterilization and transport time, preparation time and duration of intervention. The qualitative score of subjective assessment of the operator's perception of the ancillary measured during the intervention. The participants will evaluate their QOL by completing a questionnaire 3 month and 12 month postoperative. The safety parameters will also be collected.

02

Conditions studied

  • Knee Arthropathy

Browse trials for

03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's planned enrollment of 48 is below the median of 60 across 470 interventional studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient with gonarthrosis or inflammatory arthrosis of the knee leading to surgical indication for total knee arthroplasty
  • Informed patient, able to understand the information, not opposing to participate this protocol
  • patient affiliate to social security

Exclusion criteria

Exclusion Criteria:

  • Extra-joint Deformation needing bone associated gesture
  • Preoperative active or suspected infection
  • Local evolutive tumoral pathology
  • Medical history with bone gesture on concerned knee
  • Patient unable or refusing to give his consentement
  • Pregnant woman or in age to be pregnant without use any effective contraceptive method
  • Patient under maintenance of justice, tutelage or legal guardianship)
  • Presence of any family, sociological, political or geographic situation able to interfere with the protocol
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
48 participants (estimated)

Study arms

  • Active comparator
    Arm A: metallic reusable ancillary.

    This control group will be constituted of patients who will have the GMK® prosthesis with metallic reusable ancillary.

    Device: knee total arthroplasty with two types of ancillaries

  • Experimental
    Arm B: Efficiency single use ancillary.

    This group will be constituted of patients who will have the GMK® prosthesis with Efficiency single use ancillary.

    Device: knee total arthroplasty with two types of ancillaries

Interventions

  • Deviceknee total arthroplasty with two types of ancillaries

    -For the Arm A, the surgical procedure of knee total arthroplasty will be done with metallic reusable ancillary. For the Arm B, the surgical procedure of knee total arthroplasty will be done with Efficiency single use ancillary.

06

What researchers measure

Primary outcomes

  1. Mean production cost of the surgical intervention (total knee arthroplasty) each arm, from an hospital perspective, using a micro-costing approach with items reported in a eCRF

    Mean production cost of the surgical intervention in each arm is calculated thanks to 2 steps : 1) Quantification of health resources consumed during the surgical intervention (transport, cleaning, reconditionning sterilization of ancillaries, time spent by medical staff, nurses and materials used. (These data will be collected on a paper sheet and reported in a eCRF for 20 patients (10 per group)) ; 2) Valuation of health resources consumed with hospital cost accounting, mean wages, and purchase prices of materials.

    Time frame: Day 0

Secondary outcomes

  1. Incremental cost-utility ratio comparing single use ancillary versus reusable ancillary

    Incremental cost-utility ratio comparing single use versus reused ancillaries

    Time frame: 1 year

  2. clinical functional result in each group (Total KSS score)

    Total KSS score

    Time frame: 1 year postoperative

  3. clinical functional result in each arm

    Total KSS score

    Time frame: 3 months postoperative

  4. HKA angle

    HKA angle will be measured using a whole-leg radiograph (X-rays)

    Time frame: 1 year postoperative

  5. HKA angle

    HKA angle will be measured using a whole-leg radiograph (X-rays)

    Time frame: 3 months postoperative

  6. Number of Adverse events in each arm

    All complications related to the material or occurring in the postoperative year will be reported and compared (anemia, phlebitis, hematoma, scar disunity, scar necrosis, nosocomial infection, fracture)

    Time frame: 1 year postoperative

  7. Euroqol EQ-5D-5L quality-of-life questionnaire (5 questions with 5 possible answers)

    Answers to EQ-5D-5L are used to calculate QALYs which represent a measure of survival weighted by health-related quality-of-life factors so that a weight of 0 represents death and a weight of 1 represents the best imaginable health status.

    Time frame: 1 year postoperative

  8. Euroqol EQ-5D-5L quality-of-life questionnaire (5 questions with 5 possible answers)

    Answers to EQ-5D-5L are used to calculate QALYs which represent a measure of survival weighted by health-related quality-of-life factors so that a weight of 0 represents death and a weight of 1 represents the best imaginable health status.

    Time frame: 3 months postoperative

  9. qualitative score of surgeon's perception about ancillary (1-Excellent, 2-Good, 3- Difficult, 4- Unsure)

    This qualitative score will be measured during the intervention and will include 4 levels evaluating grip and comfort 1. Excellent (good position in a few seconds, no doubt) 2. Good (easy to use for the first time) 3. Difficult (several attempts, difficult handling, uncomfortable) 4. Unsure (persistence of doubt during use)

    Time frame: Day 0

  10. weight of waste

    contaminated and uncontaminated waste will be weighed at the exit of the operating room

    Time frame: Day 0

07

Study locations

1 site
  • CHU de Nantes (University Hospital of Nantes)
    Nantes, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04300439
Lead sponsor
Nantes University Hospital
Collaborators
Medacta USA
Responsible party
Sponsor
First posted
Mar 9, 2020
Start date
Mar 2020 (estimated)
Primary completion
Mar 2023 (estimated)
Completion
Mar 2023 (estimated)
Last update
Mar 9, 2020

Study contacts

Mike Persigant, MD
Contact
mike.persigant@chu-nanets.fr
02 40 08 37 78
Ingrid Bénard
Contact
ingrid.benard@chu-nantes.fr
0253482879
Mike Persigant, MD
principal investigator · Nantes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion